Elanco Animal Health Incorporated Weighted Average Number of Shares Outstanding, Basic and Diluted
Elanco Animal Health Incorporated (ELAN) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 313.70 million shares for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-20.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2019-02-20
- Elanco Animal Health Incorporated weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-12-31 was 158.00M shares, a 106.81% increase year-over-year.
- Elanco Animal Health Incorporated weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-09-30 was 365.60M shares, a 0.00% change year-over-year.
- Elanco Animal Health Incorporated weighted average number of shares outstanding, basic and diluted for the quarter ending 2017-12-31 was 76.40M shares.
- Elanco Animal Health Incorporated weighted average number of shares outstanding, basic and diluted for the quarter ending 2017-09-30 was 365.60M shares.
- Elanco Animal Health Incorporated weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 313.70M shares, a 6.96% increase from fiscal 2017.
- Elanco Animal Health Incorporated weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 293.30M shares, a 0.00% change from fiscal 2016.
- Elanco Animal Health Incorporated weighted average number of shares outstanding, basic and diluted for fiscal 2016 was 293.30M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2018-12-31 | 158.00M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | 261.80M shares derived: average of 2 quarters · filed 2019-02-20 | 313.70M shares 10-K · filed 2019-02-20 | |
| 2018-09-30 | 365.60M shares 10-Q · filed 2018-11-08 | 365.60M shares 10-Q · filed 2018-11-08 | ||
| 2017-12-31 | 76.40M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | 221.00M shares derived: average of 2 quarters · filed 2019-02-20 | 293.30M shares 10-K · filed 2019-02-20 | |
| 2017-09-30 | 365.60M shares 10-Q · filed 2018-11-08 | 365.60M shares 10-Q · filed 2018-11-08 | ||
| 2016-12-31 | 293.30M shares 10-K · filed 2019-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |